2021
When Is a Harm a Harm? Discordance between Patient and Medical Experts’ Evaluation of Lung Cancer Screening Attributes
Schapira MM, Rodriguez KL, Chhatre S, Fraenkel L, Bastian LA, Kravetz JD, Asan O, Akers S, Vachani A, Prigge JM, Meline J, Ibarra JV, Corn B, Kaminstein D. When Is a Harm a Harm? Discordance between Patient and Medical Experts’ Evaluation of Lung Cancer Screening Attributes. Medical Decision Making 2021, 41: 317-328. PMID: 33554740, DOI: 10.1177/0272989x20987221.Peer-Reviewed Original ResearchConceptsLung cancer screeningIncidental findingHarms of LCSVeterans Affairs Medical CenterRadiation exposureLung cancer deathsSignificant incidental findingsRoutine annual screeningProportion of participantsCross-sectional studyNon-Hispanic whitesPotential harmSDM discussionsAnnual screeningCancer deathCancer screeningPrimary careMortality reductionMedical CenterInvasive proceduresPatientsIndirect costsMost participantsScreening attributesOvertreatment
2002
Hormone replacement therapy and the risk of death from breast cancer: A systematic review
Nanda K, Bastian LA, Schulz K. Hormone replacement therapy and the risk of death from breast cancer: A systematic review. American Journal Of Obstetrics And Gynecology 2002, 186: 325-334. PMID: 11854659, DOI: 10.1067/mob.2002.121077.Peer-Reviewed Original ResearchConceptsHormone replacement therapy usersHormone replacement therapyRisk of deathReplacement therapyBreast cancerTherapy usersCombined hormone replacement therapyRetrievable risk estimatesBreast cancer deathsCase-control studyRecency of useAscertainment of exposurePotential confoundersCancer deathRelative riskInclusion criteriaObservational studyHistologic conditionControl groupSystematic reviewProlonged durationTherapyProlonged useCancerRisk estimates